Pricing Log in Create free account

TuHURA Biosciences, Inc. (HURA) vs LENZ Therapeutics, Inc. (LENZ)

TuHURA Biosciences, Inc. and LENZ Therapeutics, Inc. are both Biotechnology companies. TuHURA Biosciences, Inc. and LENZ Therapeutics, Inc. are of similar size ($102.6M and $94.6M). TuHURA Biosciences, Inc. has the higher net margin (0.00% vs −1,135.0%) and the lower return on invested capital (−74.2% vs 0.00%). Across the 14 metrics below, TuHURA Biosciences, Inc. leads on 7 and LENZ Therapeutics, Inc. on 7.

Valuation

Metric HURA LENZ Biotechnology median
P/E n/m n/m 10.26
P/S n/m 7.73 9.18
P/B 5.69 0.50 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.67 0.65
EV/Sales n/m (8.06) 8.98
Earnings yield (33.33%) (147.55%) (34.89%)
Free cash flow yield (28.89%) (133.70%) (24.52%)

Profitability

Metric HURA LENZ Biotechnology median
Gross margin 0.00% 85.35% 65.16%
Operating margin 0.00% (1,211.17%) 0.00%
Net margin 0.00% (1,134.97%) 0.00%
Free cash flow margin 0.00% (1,033.28%) 0.00%
Return on equity (163.84%) (72.69%) (50.12%)
Return on assets (92.31%) (66.72%) (45.60%)
Return on invested capital (74.20%) 0.00% 0.00%

Growth

Metric HURA LENZ Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 47.93% (21.79%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HURA LENZ Biotechnology median
Debt to equity 0.47 0.00 0.00
Current ratio 0.18 11.66 4.89
Net debt to EBITDA 0.12 3.22 1.01

Dividend

Metric HURA LENZ Biotechnology median
Dividend yield — 0.00% 0.41%
Payout ratio — — —

Size

Metric HURA LENZ Biotechnology median
Market cap 102.60m 94.58m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack